Subscribe

Revised International Prognostic Index (R-IPI) for a Patient with Diffuse Large B-Cell Lymphoma

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

The International Prognostic Index was developed prior to the development of rituximab. The revised IPI is a rescaling based on current outcomes.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone